Aeon (aeon.life) is a Zurich-founded preventive healthcare company on a mission to empower individuals to gain a comprehensive understanding of their health through early detection and prediction. Aeon's AI-powered platform combines whole-body MRI, capable of detecting over 500 possible anomalies across the brain, organs, and vessels, with blood diagnostics covering more than 100 biomarkers and analysis of genetic risks.
Aeon: Venture Capital Funding History
Aeon
Aeon
- Health
- London, United Kingdom
- aeon.life/en-ch
- Update Information
More venture news
- 5 Nov 2026

NayaraNayara closes a pre-seed round led by SFC Capital to support patients between appointments with AI companions
Pre-seedHealth - 4 Nov 2026

SurghiveSurghive raises a £320k seed round led by SFC Capital to train surgeons on any robotic surgery system
SeedHealth - 3 Nov 2026

1nhaler1nhaler lands a £2m follow-on round led by Archangels to test its pop-up cardboard asthma inhaler in patients
Follow-onHealth